Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06980727Phase 3Recruiting
Phase 3, randomised, double-blind trial in Renal colic comparing Placebo group, Dexamethasone group and Terbutaline group (3 arms). Primary endpoint: Change level of NRS by 50% at 120 minutes. Started Aug 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06980727.